Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Generic Rifater tablets
0501090S0AAACAC
|
Rifampicin/isoniazid | Rifampicin combined preparations | Infections | No data available |
|
Generic Viekirax 12.5mg/75mg/50mg tablets
0503032G0AAAAAA
|
Paritaprevir/ritonavir/ombitasvir | Paritaprevir/ritonavir/ombitasvir | Infections | No data available |
|
Gentamicin 240mg/80ml infusion bags
0501040H0AABDBD
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 30mg/5ml oral suspension
0501040H0AAAZAZ
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 35mg/5ml oral suspension
0501040H0AABABA
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 360mg/120ml infusion bags
0501040H0AABEBE
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 40mg/1ml solution for injection ampoules
0501040H0AAAQAQ
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 45mg/5ml oral solution
0501040H0AABFBF
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 50mg/5ml oral solution
0501040H0AAAWAW
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 5mg/1ml solution for injection ampoules
0501040H0AAAHAH
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 62.5mg/5ml oral solution
0501040H0AAAXAX
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 75mg/5ml oral solution
0501040H0AAAYAY
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin 80mg/80ml infusion bags
0501040H0AABCBC
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Gentamicin Intrathecal 5mg/1ml inj ampoules
0501040H0BHAAAH
|
Gentamicin intrathecal | Gentamicin sulfate | Infections | No data available |
|
Gentamicin Paediatric 20mg/2ml solution for injection vials
0501040H0BGAAAE
|
Gentamicin sulfate (Winthrop) | Gentamicin sulfate | Infections | No data available |
|
Genticin Injectable 80mg/2ml solution for injection ampoules
0501040H0BCAAAA
|
Genticin (Systemic) | Gentamicin sulfate | Infections | No data available |
|
Genvoya 90mg/90mg/120mg/6mg tablets
0503010BABBAAAA
|
Genvoya | Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide | Infections | No data available |
|
Glecaprevir 100mg / Pibrentasvir 40mg tablets
0503032K0AAAAAA
|
Glecaprevir/pibrentasvir | Glecaprevir/pibrentasvir | Infections | No data available |
|
Griseofulvin 1.25g/5ml oral suspension
0502050B0AACDCD
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 100mg/5ml oral suspension
0502050B0AAALAL
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 105mg/5ml oral suspension
0502050B0AABWBW
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 10mg/5ml oral suspension
0502050B0AACBCB
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 110mg/5ml oral suspension
0502050B0AACFCF
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 112.5mg/5ml oral suspension
0502050B0AAANAN
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
|
Griseofulvin 12.5mg/5ml oral suspension
0502050B0AABGBG
|
Griseofulvin (Systemic) | Griseofulvin | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.